Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study.

ABSTRACT:

Introduction

Basal insulin analogues offer persons with type 2 diabetes mellitus (T2DM) adequate glycemic control combined with a favorable safety profile. BASAL-BALI-a prospective, noninterventional, multicenter disease registry-assessed the effectiveness and safety of basal insulin analogues in adult Serbians with T2DM previously inadequately controlled on other insulin types.

Methods

The primary objective was to assess the reduction in glycated hemoglobin (HbA_1c) from basal insulin analogue initiation to the end of a 6-month observation period. Data collection was performed at three study visits: baseline, 3 months, and 6 months. All treatments and procedures were performed at the physicians' discretion.

Results

In total, 460 subjects were included. Mean

SUBMITTER: Bjekic-Macut J 

PROVIDER: S-EPMC6104277 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature